Researchers create new combination vaccine to fight Streptococcus A

June 1, 2015, Griffith University
Griffith University Professor Michael Good, of the Institute for Glycomics has developed a groundbreaking combination vaccine that may finally beat Strep A infections. Credit: Griffith University

Griffith University's Institute for Glycomics has developed a groundbreaking, combination vaccine that may finally beat Streptococcus A infections.

Human trials are set to begin, early as next year, for the vaccine which combines the protein, SpyCEP, with a previously developed vaccine J8-DT.

Infections caused by Streptococcus pyogenes are responsible for the deaths of almost 500,000 people worldwide each year. It is particularly prevalent in and Indigenous populations, including Aboriginal people and Torres Strait Islanders.

Infections can range from tonsillitis and what is commonly known as 'schools sores', to life threatening diseases where deep tissues are infected.

If left untreated infections can give rise to the very serious condition of .

Principal Research Leader at the Institute for Glycomics, Professor Michael Good said the team's latest research, which is published in the current issue of the Journal of Immunology, shows that they are getting closer to beating Strep A once and for all.

"We have successfully vaccinated mice with a vaccine that we believe will be suitable for humans," he said.

"We will spend the next six months developing that vaccine at a high level of purity suitable for humans and hope to start a clinical trial next year."

The inspiration to use SpyCEP came to Professor Good during a conference in Rome three years ago. He then thought of combining it with the J8-DT vaccine.

"While Strep A can cause tonsillitis or school sores, it can sometimes develop a mutation in its DNA which causes the organism to spread to other tissues in your body," he said.

"This is when it becomes dangerous and 10-15 per cent of infected people will die when that happens. But we have worked out how to combat that virulence.

"We vaccinated the mice with a protein which induces antibodies that protect the white cells that are needed to battle the when a mutation occurs.

"When the can work, they can attack the organism as long as there are other antibodies there. And this is when the J8-DT vaccine comes in."

Professor Good said it was the combination of the two vaccines that he believes will be highly effective.

Explore further: Human trials for Streptococcus A vaccine

More information: Journal of Immunology, www.jimmunol.org/content/early … 500157.full.pdf+html

Related Stories

Human trials for Streptococcus A vaccine

February 28, 2013
Griffith University's Institute for Glycomics has launched human trials for a vaccine against Streptococcus A, the germ that causes rheumatic fever.

New hopes for rheumatic fever vaccination

March 19, 2015
A new vaccine to combat the debilitating disease caused by rheumatic fever may soon become a reality, saving hundreds of thousands of deaths from preventable heart disease around the world each year.

Norovirus candidate vaccine induces broad antibody responses in trial participants

March 24, 2015
A multivalent candidate vaccine elicits broad antibody responses to a range of norovirus strains, including strains not included in the vaccine or previously encountered by participants, according to a new study published ...

Researchers devise vaccine that provides long-term protection against Chagas disease

May 7, 2015
Researchers from The University of Texas Medical Branch at Galveston have successfully tested a vaccine for Chagas disease, which is widespread in Latin America but is beginning to show up in the U.S. - including the Houston ...

Researcher develops bird flu vaccine using virus commonly found in dogs

May 6, 2015
Researchers at the University of Georgia have used a virus commonly found in dogs as the foundation for a new vaccine against H7N9 influenza, more commonly known as bird flu.

Beating the clock: Researchers develop new treatment for rabies

January 26, 2015
Successfully treating rabies can be a race against the clock. Those who suffer a bite from a rabid animal have a brief window of time to seek medical help before the virus takes root in the central nervous system, at which ...

Recommended for you

Drinking baking soda could be an inexpensive, safe way to combat autoimmune disease: study

April 25, 2018
A daily dose of baking soda may help reduce the destructive inflammation of autoimmune diseases like rheumatoid arthritis, scientists say.

Scientists unearth vital link between fat, immunity and heat regulation

April 24, 2018
Scientists have just made a surprising discovery involving fat and special immune cells that live within it—it turns out that 'gd T cells' are the key cogs in the biological wheel that regulates our body heat and protects ...

Immune response might be stunting growth in millions of kids

April 24, 2018
An overactive immune system during childhood among young people in Ecuador's indigenous Shuar population comes with a cost: stunted growth.

Odd one out: Protein goes against the family to prevent cancer

April 23, 2018
Melbourne researchers have made the surprise discovery that the 'odd one out' in a family of proteins known to drive cancer development is instead critical for preventing stomach cancers.

Research debunks 'myth' that strenuous exercise suppresses the immune system

April 20, 2018
New research overturns a myth that has persisted for nearly four decades - that competing in endurance sports, like this weekend's London Marathon, suppresses the body's immune system and makes competitors more susceptible ...

Immune diversity among the KhoeSan population

April 20, 2018
A new study of the KhoeSan of Southern Africa has improved the understanding of immune diversity among the oldest surviving indigenous population in the world.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.